All In Biotech

Free tool

FAERS Monitor: Avapro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020757 or its brand name (Avapro, Irbesartan). Reports on generic versions are filed under their own applications.

Reports

45,095

Serious

35,266

78% of reports

Hospitalization

19,285

Death reported

3,341

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,569
  • nausea2,514
  • diarrhoea2,369
  • drug ineffective2,237
  • acute kidney injury2,187
  • dizziness2,059
  • dyspnoea2,058
  • fall2,038
  • headache1,966
  • off label use1,773
  • asthenia1,767
  • malaise1,700
  • vomiting1,595
  • pain1,591
  • blood pressure increased1,537

Reports by year received

View as table
YearReports
2004834
20051,000
20061,052
20071,194
20081,227
20091,312
20101,329
20111,484
20121,514
20131,209
20141,486
20151,794
20161,991
20171,947
20182,715
20193,633
20203,369
20212,778
20222,931
20232,893
20242,637
20252,763
20262,001

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,009,064 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal2,1876.76.510,626
blood pressure increasedSignal1,5374.74.54,499
fallSignal2,0382.92.72,501
astheniaSignal1,7672.22.11,167
dizziness2,0591.91.8939
malaise1,7001.81.7627
diarrhoea2,3691.71.6724
dyspnoea2,0581.71.6604
vomiting1,5951.61.5350
fatigue2,5691.51.5504
nausea2,5141.51.4409
headache1,9661.51.4297
pain1,5911.21.259
off label use1,7730.90.96
drug ineffective2,2370.80.8131

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.